As has already been widely reported, on Friday 29 June 2012 the European Council agreed on what has been presented as the final step on the long road to the Unitary EU Patent and a Unified European Patent Court.
Apple is closing the gap to making full virtual reality a possibility. On July 24th 2012, the U.S. Patent and Trademark Office granted the company a patent for its groundbreaking 5 dimensional technology. The Invention will incorporate virtual reality gloves, next generation sensors and touch screens to better immerse a user.
A somewhat confusing victory for Allergan Inc. was won on June 18th, as the Honourable Justice Hughes upheld their patent on COMBIGAN despite the fact that their invention was ruled to be obvious. The Honourable Justice Hughes ruled in favour of Allergan by prohibiting the Minister of Health from issuing a Notice of Compliance (NOC) […]
Koninklijke Philips Electronics N.V. has survived a challenge against its “Display Device” patent by DSM IP Assets B.V. in a ruling by the Boards of Appeal of the European Patent Office (EPO) that tries to clarify the law around public disclosure of a patent and the use of email.
Canada has been lobbying to enter the Trans-Pacific Partnership (TPP), and its efforts have seemingly paid off with an exclusive invite to the secretive nine-member club on June 19, 2012. With Ottawa championing its economic benefits and potential, there are many asking a simple question – what have we given up?
At the Rio + 20 United Nations Conference on Sustainable Development — which followed by forty years the Stockholm Declaration of the United Nations Conference on the Human Environment and by twenty years the Rio Declaration on Environment and Development — the negotiators sought to “reinvigorate political will and raise the level of commitment by […]
In late March, The United States Supreme Court ordered the U.S Court of Appeal for the Federal Circuit to reconsider Myriad Genetics’ existing patent on two genes associated with a high risk of breast and ovarian cancer, in light of the judgement rendered in Mayo Collaborative Services v Prometheus Labs (Prometheus). A unanimous Supreme Court […]
On June 16, 2012, the Canada Gazette, published the proposed new regulations formalizing procedures before the Patented Medicine Prices Review Board (the Board). These proposed new regulations represent an effort to enhance the efficiency of hearings before the Board through the formal adoption of codified practices and terminology already utilized by the board; the incorporation […]
In a bold move, China has rewritten parts of its intellectual property laws to allow for Chinese companies to make generic copies of life-saving medication still under patent. These domestically produced drugs will be offered for substantially less than what their North American and European pharmaceutical competitors currently charge. The changes will provide local drug […]
In an effort to draw a line in the sand in the smartphone market, an “innocent bystander” has been caught in the legal crossfire. Following a successful sales ban of the Xbox 360 in Germany, Motorola set its sights on the gaming console’s home turf, and currently, things are not looking good for Microsoft in […]